Serum CCL21 as a Potential Biomarker for Cognitive Impairment in Spinal Cord Injury

Table 3

Multivariable analyses of risk factors with MoCA in SCI.

	Regression coefficient		95% CI
Age (years)	0.181	0.219	0.108-1.275
Male	0.346	0.393	0.298-1.201
BMI (kg/m^2)	0.239	0.168	0.117-1.093
TG (mmol/L)	0.256	0.475	0.162-1.154
LDL-C (mmol/L)	0.266	0.311	0.143-1.138
FBG (mmol/L)	0.398	0.279	0.154-1.219
SBP (mmHg)	0.387	0.638	0.229-1.132
DBP (mmHg)	0.309	0.446	0.195-1.213
CCL21 (pg/ml)	0.328	0.027	0.202-0.807

MoCA: Montreal Cognitive Assessment; SCI: spinal cord injury; BMI: body mass index; TG: triglycerides; LDL-C: low-density lipoprotein cholesterol; FBG: fasting plasma glucose; SBP: systolic blood pressure; DBP: diastolic blood pressure; CCL21: chemokine (C-C motif) ligand 21.